ZNTL
Zentalis Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.71
-0.04 ▼ -1.45%
🌙 3월 13일 4:22 PM ET (한국 3/14 05:22)
$2.69
-0.02 ▼ -0.74%
| Index | - | P/E | - | EPS (ttm) | -2.08 | Insider Own | 31.38% | Shs Outstand | 0.07B | Perf Week | 18.08% |
| Market Cap | 0.20B | Forward P/E | - | EPS next Y | -2.33% | Insider Trans | -4.61% | Shs Float | 0.05B | Perf Month | 11.52% |
| Enterprise Value | -0.04B | PEG | - | EPS next Q | -0.43 | Inst Own | 60.36% | Short Float | 7.62% | Perf Quarter | 90.85% |
| Income | -0.15B | P/S | 7.29 | EPS this Y | 21.73% | Inst Trans | -17.42% | Short Ratio | 2.69 | Perf Half Y | 73.72% |
| Sales | 0.03B | P/B | 0.77 | EPS next 5Y | 12.28% | ROA | -38.39% | Short Interest | 3.78M | Perf YTD | 100.74% |
| Book/sh | 3.5 | P/C | 0.7 | EPS past 3/5Y | 14.39% -12.89% | ROE | -49.18% | 52W High | -31.39% ($3.95) | Perf Year | 49.72% |
| Cash/sh | 3.89 | P/FCF | - | Sales past 3/5Y | - | ROIC | -51.56% | 52W Low | 168.32% ($1.01) | Perf 3Y | -83.98% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 17.54% | Gross Margin | 96.65% | Volatility(W/M) | 12.45% 8.98% | Perf 5Y | -94.67% |
| Dividend TTM | - | EV/Sales | -1.65 | Sales Y/Y TTM | -33.76% | Oper. Margin | -567.95% | ATR (14) | 0.25 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 7.76 | EPS Q/Q | 34.48% | Profit Margin | -555.8% | RSI (14) | 54.53 | Recom | 2.11 |
| Dividend Gr. 3/5Y | - | Current Ratio | 7.76 | Sales Q/Q | - | SMA20 | 8.03% ($2.51) | Beta | 1.63 | Target Price | $5.31 |
| Payout | - | Debt/Eq | 0.16 | Earnings | 11000000 | SMA50 | 5.1% ($2.58) | Rel Volume | 0.28 | Prev Close | $2.75 |
| Employees | 166 | LT Debt/Eq | 0.15 | EPS/Sales Surpr. | 29.9% - | SMA200 | 55.68% ($1.74) | Avg Volume(3M) | 1.40M | Price | $2.71 |
| IPO | 2020/4/3 | Option/Short | Yes/Yes | Trades | 3750 | Volume | 396,791 | Change | -1.45% |
뉴스 로딩 중...